Carregant...
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
BACKGROUND: Despite its common use in cancer treatment, radiotherapy has not yet entered the era of precision medicine, and there have been no approaches to adjust dose based on biological differences between or within tumours. We aimed to assess whether a patient-specific molecular signature of rad...
Guardat en:
| Publicat a: | Lancet Oncol |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7771305/ https://ncbi.nlm.nih.gov/pubmed/27993569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30648-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|